MENGENAI EPISOD INI
Multiple System Atrophy progresses faster than Parkinson's, attacks multiple systems at once, and takes an average of seven doctors before patients receive the correct diagnosis. There is currently no approved treatment.
On this episode of Vantage Point Podcast, we sit down with David Stamler (CEO) and Daniel Claassen (CMO) of Alterity Therapeutics to discuss their drug candidate ATH434, phase two results showing nearly 50% reduction in disease progression rate, and the path to a phase three trial.
We also cover Alterity's orphan drug and fast track FDA designations, upcoming phase three study design discussions, and the drug's potential beyond MSA - including Parkinson's and Friedreich's Ataxia.
Bahasa Inggeris
Australia
TRANSKRIP 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CARI EPISOD LEPAS
Cari episod lepas bagi Vantage Point: Driving Success in the Australian Market.
EPISOD LAIN DALAM PODCAST INI
On the latest episode of Vantage Point Podcast, Nick Leitl joinsus to discuss the journey from fund manager to co-founder of LSN Capital Partners and what it takes to build and grow an investment business from the ground up.
Drawing on more than two decades in markets, including 16 years managin ...
In this episode we’re joined by Executive Chairman of Green360 (GT3:ASX), Aaron Banks.
Cement is the second most consumed product on earth after water, and the industry generates roughly 8% of global emissions — the equivalent of the entire global car fleet. Yet the chemistry behind it hasn’t m ...
Most businesses are using AI the same way; typing prompts into ChatGPT or Claude and hoping for the best. As business usage proliferates during the rush to harness AI, the question of who governs these models, and how, is becoming one of the most important problems the world must face.
On the la ...
Elsight (ASX: ELS) is the connectivity layer powering the world’s drones and unmanned systems, and the company’s transformation over the past 12 months has been one of the most compelling operational stories on the ASX.
We sat down with Yoav Amitai, CEO of Elsight, who joined the company as an ...
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada NWR Communications, yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.
SUNTING
Terima kasih kerana membantu memastikan pangkalan data podcast dalam keadaan terkini.
